Skip to main content
A phase I trial of sns-314, a novel and selective pan-aurora kinase inhibitor, in advanced solid tumor patients Robert, F., Verschraegen, C., Hurwitz, H., Uronis, H., Advani, R., Chen, A., Taverna, P., Wollman, M., Fox, J., Michelson, G. AMER SOC CLINICAL ONCOLOGY. 2009

View details for Web of Science ID 000276606602302